Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGF-1 and UVB Response in Young vs Geriatric Skin
NCT03932162Phase 1Recruiting
- Sponsor
- Wright State University
- Start
- Sep 2019
- Primary completion
- Dec 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of mecasermin in Skin aging (2 arms), sponsored by Wright State University. Primary endpoint: Change in expression genes involved in protecting skin cells from UVB damage at 2 days. Started Sep 2019; status: recruiting.
02
Drugs
mecasermin
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT03932162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03932162.